Related Experiment Video
Updated: Aug 11, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
A review on the roles and molecular mechanisms of MAFG-AS1 in oncogenesis
Khazar Ghasempour Dabbaghi1, Noushin Mashatan2, Omid Faraz3
1Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract:
Long non-coding RNAs (lncRNAs) have more than 200 nucleotides and do not encode proteins. At the same time, they can regulate various biological functions and therefore play an essential role as oncogenes or tumor suppressors in human cancers. MAFG-AS1 is an antisense RNA of MAF BZIP Transcription Factor G (MAFG) located at chromosome 17q25.3 head-to-head with the MAFG encoding gene containing a transcript size of 1895 bp. Accumulating evidence shows that MAFG-AS1 is overexpressed in many cancers, functions as an oncogene, and is significantly associated with poor clinical characteristics and prognosis. In this review, we first discuss the recent literature regarding the role of MAFG-AS1 in different cancers as well as its diagnostic and prognostic values. Then we will provide insights into its biological functions, such as its role in cancer progression, competing endogenous RNA (ceRNA) activity, regulation of EMT, glycolysis, energy metabolism, transcription factors, proteasomal degradation, and signaling pathways.
Insights
Long non-coding RNA MAFG-AS1 acts as an oncogene in various cancers, impacting progression and patient prognosis. This review explores its diagnostic, prognostic, and functional roles in cancer.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Long non-coding RNAs (lncRNAs) are key regulators of biological functions, including cancer.
- MAFG-AS1, an antisense RNA to MAFG, is implicated in various human cancers.
Purpose of the Study:
- To review the literature on MAFG-AS1's role in different cancers.
- To discuss its diagnostic and prognostic values.
- To provide insights into its biological functions in cancer.
Main Methods:
- Literature review of studies on MAFG-AS1 in human cancers.
- Analysis of MAFG-AS1's association with clinical characteristics and prognosis.
- Examination of MAFG-AS1's molecular mechanisms.
Main Results:
- MAFG-AS1 is overexpressed in numerous cancers and linked to poor prognosis.
- MAFG-AS1 exhibits oncogenic activity across various cancer types.
- Evidence suggests MAFG-AS1 influences cancer progression, EMT, and metabolism.
Conclusions:
- MAFG-AS1 is a significant oncogene with diagnostic and prognostic implications in cancer.
- Understanding MAFG-AS1's functions can reveal novel therapeutic targets.
- Further research into MAFG-AS1 pathways is warranted for cancer treatment.
Related Concept Videos
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
TGF - β Signaling Pathway
Abnormal Proliferation
Master Transcription Regulators

